Ir directamente a la navegación principal
Ir directamente a la búsqueda
Ir directamente al contenido principal
Pontificia Universidad Javeriana Inicio
Ayuda y preguntas frecuentes
El enlace se abre en una pestaña nueva
Español
English
Buscar contenido en Pontificia Universidad Javeriana
Inicio
Perfiles
Unidades
Productos
Proyectos
Laboratorios y Equipos
Cursos
Actividades
Premios
Medios
Conjuntos de datos
Impacto
Tesis
Basal insulin and cardiovascular and other outcomes in dysglycemia
The Origin Trial Investigators
Departamento de Medicina Interna
Hospital Universitario San Ignacio
McMaster University and Hamilton Health Sciences
Université Laval
Estudios Clínicos Latinoamérica
Associazione Nazionale Medici Cardiologi Ospedalieri
University of Washington
India Diabetes Research Foundation
Oregon Health and Science University
Karolinska Institutet
Producción
:
Contribución a una revista
›
Artículo
›
revisión exhaustiva
1526
Citas (Scopus)
Información general
Huella
Huella
Profundice en los temas de investigación de 'Basal insulin and cardiovascular and other outcomes in dysglycemia'. En conjunto forman una huella única.
Clasificar por
Ponderación
Alfabéticamente
Keyphrases
Basal Insulin
100%
Dysglycemia
100%
Insulin Glargine
100%
95% Confidence Interval
66%
Hazard Ratio
50%
Fasting Blood Glucose
50%
Diabetes
33%
Hypoglycemia
33%
Care Groups
33%
Cardiovascular Outcomes
33%
No Significant Difference
16%
In Cancer
16%
Placebo
16%
Type 2 Diabetes Mellitus (T2DM)
16%
Cardiovascular Events
16%
Odds Ratio
16%
Impaired Fasting Glucose
16%
Nonfatal Myocardial Infarction
16%
Nonfatal Stroke
16%
Severe Hypoglycemia
16%
Impaired Glucose Tolerance
16%
Incident Diabetes
16%
Heart Failure Hospitalization
16%
Revascularization
16%
New-onset Diabetes
16%
Vascular Outcomes
16%
Cancer Hazard
16%
N-3 Fatty Acids
16%
Cardiovascular Risk Factors
16%
Neutral Effects
16%
Two-factor Designs
16%
Incident Cancer
16%
Medicine and Dentistry
Dysglycemia
100%
Insulin Glargine
100%
Cardiovascular System
100%
Insulin
100%
Diabetes
66%
Cancer
50%
Hazard Ratio
50%
Hypoglycemia
33%
Care Group
33%
Glucose
33%
Maturity Onset Diabetes of the Young
16%
Apoplexy
16%
Cardiovascular Risk
16%
Myocardial Infarction
16%
Impaired Glucose Tolerance
16%
Impaired Fasting Glucose
16%
Congestive Heart Failure
16%
Revascularization
16%
Blood Glucose
16%
Placebo
16%
Omega-3 Fatty Acid
16%
Odds Ratio
16%
Severe Hypoglycemia
16%
Median Follow Up
16%
INIS
insulin
100%
glucose
62%
fasting
50%
levels
37%
cancer
37%
weight
37%
hazards
37%
comparative evaluations
25%
plasma
25%
incidents
25%
design
12%
range
12%
risks
12%
death
12%
blood
12%
therapy
12%
people
12%
heart failure
12%
fatty acids
12%
myocardial infarction
12%
tolerance
12%